Akoya Biosciences Inc (AKYA)
4.04
+0.05
(+1.25%)
USD |
NASDAQ |
May 03, 14:50
Akoya Biosciences Cash from Investing (Quarterly): -0.594M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.594M |
| September 30, 2023 | -0.832M |
| June 30, 2023 | -1.423M |
| March 31, 2023 | 6.196M |
| December 31, 2022 | 22.13M |
| September 30, 2022 | 7.266M |
| June 30, 2022 | -42.34M |
| March 31, 2022 | -1.138M |
| Date | Value |
|---|---|
| December 31, 2021 | -1.365M |
| September 30, 2021 | -1.875M |
| June 30, 2021 | -0.947M |
| March 31, 2021 | -0.907M |
| December 31, 2020 | 9.653M |
| September 30, 2020 | -0.902M |
| June 30, 2020 | -0.588M |
| March 31, 2020 | -1.435M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-42.34M
Minimum
Jun 2022
22.13M
Maximum
Dec 2022
-0.5686M
Average
-0.9045M
Median
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp | -36.80M |
| Azenta Inc | 98.40M |
| Harvard Bioscience Inc | -1.061M |
| Bionano Genomics Inc | -55.37M |
| Singular Genomics Systems Inc | 0.651M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.584M |
| Cash from Financing (Quarterly) | 11.08M |
| Free Cash Flow | -54.55M |
| Free Cash Flow Per Share (Quarterly) | -0.1244 |
| Free Cash Flow to Equity (Quarterly) | -17.61M |
| Free Cash Flow to Firm (Quarterly) | -4.801M |
| Free Cash Flow Yield | -30.41% |